newsfilter
← Latest News
GlobeNewswire·

Paratek Pharmaceuticals Acknowledges Receipt of NexPoint Letter

BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ("Paratek") (NASDAQ:PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapies for